Related Experiment Video
Updated: Jan 19, 2026
A Technique to Generate an Adjuvant-Induced Arthritis Mouse Model
Insights
Septic arthritis in children, often caused by Staphylococcus aureus, requires prompt diagnosis and treatment to avoid long-term issues. Treatment typically involves a 10-day to 4-week course of antibiotics, with shorter IV courses often sufficient.
Area of Science:
- Pediatric infectious diseases
- Pediatric rheumatology
- Orthopedic infectious diseases
Background:
- Septic arthritis affects 4-10 per 100,000 children annually in developed nations, with a peak incidence around age 3.
- Staphylococcus aureus is the most frequent pathogen, though microbial causes vary with patient age.
- Timely diagnosis and intervention are crucial to prevent lasting joint damage and disability.
Purpose of the Study:
- To outline the epidemiology, diagnosis, and management of pediatric septic arthritis.
- To emphasize the importance of early treatment to minimize sequelae.
- To guide empiric antibiotic selection and duration based on age and likely pathogens.
Main Methods:
- Review of current literature and clinical guidelines on pediatric septic arthritis.
- Analysis of epidemiological data regarding incidence and causative organisms.
- Discussion of diagnostic criteria and therapeutic strategies, including antibiotic choice and duration.
Main Results:
- The incidence is 4-10 cases per 100,000 child-years, peaking at age 3.
- Staphylococcus aureus is the predominant organism, but microbiology differs by age group.
- Empiric therapy should target common pathogens, with treatment duration ranging from 10 days to 4 weeks.
Conclusions:
- Prompt diagnosis and treatment of pediatric septic arthritis are essential for favorable outcomes.
- Antibiotic therapy, often initiated empirically, should be tailored to the patient's age and likely pathogens.
- A short course of intravenous antibiotics is frequently adequate, but total treatment duration varies.
Abstract:
The incidence of septic arthritis among children in developed countries is estimated to be 4 to 10 cases per 100,000 children per year, peaking at about age 3 years. The most common causative organism is Staphylococcus aureus, although the microbiology varies by age. Prompt diagnosis and treatment is critical to prevent long-term sequelae. Empiric therapy should target the most likely causative organism(s) and total duration generally falls between 10 days and 4 weeks depending on clinical course, patient age, and organism. A short intravenous course is sufficient in most cases. Unusual and alternate causes of arthritis should be considered in special cases. [Pediatr Ann. 2019;48(9):e354-e359.].
Related Concept Videos
03:29A Technique to Generate an Adjuvant-Induced Arthritis Mouse Model
03:52A Cell-Based Therapy for Autoimmune Arthritis in a Murine Model
07:37An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
09:04In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
09:18Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients